Personalis & BC Cancer Assess Benefits of ctDNA for Colorectal, Pancreatic Cancers
Personalis and BC Cancer will deploy a personalized liquid biopsy-based assay for a study of patients with colorectal and pancreatic cancers.
Read MorePosted by Andy Lundin | Aug 15, 2022 | Colorectal, Pancreatic |
Personalis and BC Cancer will deploy a personalized liquid biopsy-based assay for a study of patients with colorectal and pancreatic cancers.
Read MorePosted by Andy Lundin | Aug 15, 2022 | Company News |
BD will offer Accelerate Diagnostic’s rapid testing solution for antibiotic resistance and susceptibility, which provides results in hours.
Read MorePosted by Andy Lundin | Aug 8, 2022 | Sexually Transmitted Diseases |
Keystone Laboratories will now be testing hepatitis and HIV panels at its in-house lab located in Asheville, North Carolina.
Read MorePosted by Andy Lundin | Aug 8, 2022 | Covid 19, Point-of-Care |
A new POC diagnostic device can simultaneously detect the presence of both SARS-CoV-2 RNA & antibodies against the virus in saliva.
Read MorePosted by Andy Lundin | Aug 5, 2022 | Covid 19 |
A new COVID testing method is set for a global rollout after its commercial rights were licensed to COVID-19 test provider, Innova Medical.
Read More